Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-05-17

Clinical Trial Update: More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating fluorescence-guided surgery for removing malignant brain tumors has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Constantinos Hadjipanayis | Conditions: Benign Neoplasms, Brain, Brain Cancer | Phase 2 | Status: WITHDRAWN